Home > Insider Trading > Filing (0000904454-15-000512)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404644	Aquinox Pharmaceuticals Inc	AQXP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
200406	Johnson & Johnson	One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		No	No	Yes	No
924020	Johnson & Johnson Innovation - Jjdc, Inc.	One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-08-10	231,455	$31.66	1,383,366	No	4	S	Indirect	Johnson & Johnson Innovation - JJDC, Inc.
Common Stock	Disposition	2015-08-11	1,283,366	$20.74	100,000	No	4	S	Indirect	Johnson & Johnson Innovation - JJDC, Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Johnson & Johnson Innovation - JJDC, Inc.
No	4	S	Indirect	Johnson & Johnson Innovation - JJDC, Inc.

Footnotes

The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person. Johnson & Johnson Development Corporation changed its name to Johnson & Johnson Innovation - JJDC, Inc. on November 3, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $41.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.55 to $30.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.